Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not?

Area of Science:

• Oncology
• Cancer Biology
• Tumor Microenvironment

Background:

• Cancer cells require oxygen and nutrients for survival.
• Anti-angiogenic therapies aim to starve tumors by restricting blood supply, often delaying progression.
• Emerging evidence suggests tumor hypoxia can paradoxically promote invasion and metastasis.

Purpose of the Study:

• To discuss the link between hypoxia signaling and cancer metastasis.
• To explore how vascular-targeting strategies impact tumor oxygenation and metastasis.
• To review findings on hypoxia-induced invasive switches.

Main Methods:

• Review of genetic studies in mice.
• Analysis of clinical experience with anti-angiogenic agents.
• Discussion of emerging evidence on hypoxia and metastasis.

Main Results:

• Hypoxia resulting from tumor microvasculature pruning can promote invasion and metastasis in certain contexts.
• Vascular-targeting strategies that mitigate or reverse tumor hypoxia may prevent metastasis.
• Hypoxia signaling is intricately linked to multiple steps of the metastatic cascade.

Conclusions:

• The role of hypoxia in metastasis is complex and context-dependent.
• Therapeutic strategies should consider the impact on tumor oxygenation to avoid promoting metastasis.
• Further research into hypoxia signaling pathways is crucial for developing effective anti-metastatic treatments.